Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Staphylococcus coli

I believe that now, when definite and secure foundations have been laid for the scientific principles. ..of chemotherapeutics, the way is visible before us. In the diseases involving protozoa and spirilla (ie trypanosomal diseases and syphilis) extraordinarily favourable results...have already been gained.... But in contradistinction to these diseases. the common bacterial diseases (diseases due to streptococcus, staphylococcus, coli, typhoid, dysentery but above all tuberculosis) will require a hard struggle. These words were to prove highly prophetic. [Pg.10]

Specific bacteriostatic activity against Escherichia coli (681, 896, 899), Staphylococcus aureus (681, 896), Cocci (900), Shigella dysenteriae (681), Salmonella ryphi (681), Proteus vulgaris (681), Pseudomonas aeruginosa (681), Streptococcus (889, 901, 902) and Pneumococcus (901-904). [Pg.152]

Proper refrigeration prevents the growth of some microorganisms, such as Salmonella and the production of toxins, such as Staphylococcus aureus. The growth of bacteria Tscherichia coli and Bacillus cereus is substantially checked by proper cooling and handling of milk. Table 14 Hsts diseases transmitted by cows to humans. Pasteurization is the best means of prevention. [Pg.364]

Streptococcus pyogenes Streptococcusfaecalis and Staphylococcus aureus show a markedly greater susceptibihty to its action than Escherichia coli and Pseudomonas aeruginosa (205). Thiram has been used ia disiafectant soaps. [Pg.132]

Neamine Neomydn Ribostamydn Gentamicins A, B, Cia. c2 Kanamydn B Sisomidn Tobramydn Dihydrostreptomydn Pseudomonas aeruginosa Escherichia coli Pseudomonas aeruginosa Escherichia coli Staphylococcus aureus 3 -0-Phosphorylated Pseudomonas aeruginosa derivatives of the respective substrates ... [Pg.189]

The sulfonamides are often used to control urinary tract infections caused by certain bacteria such as Escherichia coli, Staphylococcus aureus, and Klebsiella-Enterobacter. Mafenide (Sulfamylon) and silver sulfadiazine (Silvadene) are topical sulfonamides used in the treatment of second- and third-degree bums. Additional uses of the sulfonamides are given in the Summary Drug Table The Sulfonamides. [Pg.59]

Bacterial agents, particularly Staphylococcus aureus, P-hemolytic streptococci, and Escherichia coli may give rise to pyomyositis, a form of acute suppurative... [Pg.333]

In the cell-wall antigen from Staphylococcus aureus M, taurine is linked as an amide (51) to a 2-acetamido-2-deoxy-D-galactosyluronic residue. l-Threonine and L-glutamic acid are linked as amides to D-glucuronic acid residues in the LPS from Rhodopseudomonas sphaeroides ATCC 17023 and in the capsular polysaccharide from Klebsiella K82, respectively. In the capsular polysaccharide from E. coli K54, L-serine and L-threonine, in the ratio 1 9, are linked to the carboxyl group of a D-glucuronic acid residue. In the capsular polysaccharide from Haemophilus influenzae type d,... [Pg.312]

Bacterial resistance to antibiotics has been recognized since the first drugs were introduced for clinical use. The sulphonamides were introduced in 1935 and approximately 10 years later 20% of clinical isolates of Neisseria gonorrhoeae had become resistant. Similar increases in sulphonamide resistance were found in streptococci, coliforms and other bacteria. Penicillin was first used in 1941, when less than 1 % of Staphylococcus aureus strains were resistant to its action. By 1947,3 8% of hospital strains had acquired resistance and currently over 90% of Staph, aureus isolates are resistant to penicillin. Increasing resistance to antibiotics is a consequence of selective pressure, but the actual incidence of resistance varies between different bacterial species. For example, ampicillin resistance inEscherichia coli, presumably under similar selective pressure as Staph, aureus with penicillin, has remained at a level of 30-40% for mai years with a slow rate of increase. Streptococcus pyogenes, another major pathogen, has remained susceptible to penicillin since its introduction, with no reports of resistance in the scientific literature. Equally, it is well recognized that certain bacteria are unaffected by specific antibiotics. In other words, these bacteria have always been antibiotic-resistant. [Pg.181]

Deformylation of nascent polypeptides has been shown to be a function essential for growth in E. coli, Staphylococcus aureus and Streptococcus pneumoniae [15-18]. Moreover, antibacterial mode of action studies, using S. pneumoniae or S. aureus strains in which the expression of PDF is controlled by regulatable promoters, have shown that the antibacterial activity of PDF inhibitors is due to their inhibition of the PDF enzyme, as the susceptibility of the strains to these compounds is dependent on the amount of protein present in the cell [19-21]. These results further validate PDF as a target for novel antibiotics. [Pg.112]

Acute pancreatitis can progress to several distinct consequences. Pancreatic fluid collections and pancreatic abscesses can form during the course of acute pancreatitis. Pancreatic necrosis can occur when pancreatic enzymes damage the pancreatic tissue or when pancreatic abscesses become secondarily infected. This infection is usually due to bacteria that are normally found in the gastrointestinal tract, including Escherichia coli, Enterobacteriaceae, Staphylococcus aureus, viridans group streptococci, and anaerobes. [Pg.338]

Each year in the United States, approximately 76 million food-borne illnesses occur, leading to 325,000 hospitalizations and over 5000 deaths.40 A number of bacterial and viral pathogens that have been discussed previously in this chapter (e.g., Salmonella, Shigella, Campylobacter, E. coli, and noroviruses) can cause food poisoning. Other bacteria that can cause foodborne illness include Staphylococcus aureus, C. perfringens, C. botu-linum, and Bacillus cereus (Table 73-5). Food poisoning should be suspected if at least two individuals present with similar symptoms after the ingestion of a common food in the prior 72 hours. [Pg.1126]

Primary peritonitis generally is caused by a single organism (.Staphylococcus aureus in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) and Escherichia coli in patients with cirrhosis). [Pg.1129]

The majority (85%) of uncomplicated UTIs are caused by Escherichia coli. The remaining 15% are caused by Klebsiella spp., Staphylococcus saprophyticus, Enterococcus spp., Proteus spp., and other organisms. [Pg.1151]

Hematogenous Neonates Prepubertal children Long bones (femur, tibia) Long bones (femur, tibia) Staphylococcus aureus,3 E. coli, group B streptococci 5. aureus Nafcillin and cefotaxime Nafcillin or cefazolin... [Pg.1179]

Active ingredient % in plastic Staphylococcus aureus Streptococcus faecium Pseudomonas aeruginosa Escherichia coli... [Pg.107]

Characterization of Anti-Infective Biological Activity. Acute sepsis models utilizing either Escherichia coli or Staphylococcus aureus intraperitoneal challenge were developed to evaluate the anti-infective properties of PGG in mice. [Pg.47]

The types of microorganisms found in various products are Pseudomonas species, including Pseudomonas aeruginosa, Salmonella, species, Staphylococcus aureus, and Escherichia coli. The USP and other pharmacopoeias recommend certain classes of products to be tested for specified microbial contaminants, e.g., natural plant, animal, and some mineral products for the absence of Salmonella species, suspensions for the absence of E. coli, and topically administered products for the absence of P. aeruginosa and S. aureus. Emulsions are especially susceptible to contamination by fungi and yeasts. Consumer use may also result in the introduction of microorganisms. For aqueous-based products, it is therefore mandatory to include a preservative in the formulation in order to provide further assurance that the product retains its pharmaceutically acceptable characteristics until it is used by the patient. [Pg.259]

In microbes without a permeability barrier, or when the barrier fails, a mechanism must be in place to export metals from the cytoplasm. These active transport systems involve energy-dependent, membrane-bound efflux pumps that can be encoded by either chromosomal- or plasmid-borne genes. Active transport is the most well-studied metal resistance mechanism. Some of these include the ars operon for exporting arsenic from E. coli, the cad system for exporting cadmium from Staphylococcus aureus, and the cop operon for removing excess copper from Enterococcus hiraeP i9A0... [Pg.410]


See other pages where Staphylococcus coli is mentioned: [Pg.481]    [Pg.411]    [Pg.303]    [Pg.23]    [Pg.123]    [Pg.125]    [Pg.199]    [Pg.247]    [Pg.75]    [Pg.1056]    [Pg.187]    [Pg.17]    [Pg.310]    [Pg.166]    [Pg.238]    [Pg.114]    [Pg.151]    [Pg.172]    [Pg.250]    [Pg.250]    [Pg.257]    [Pg.226]    [Pg.240]    [Pg.1131]    [Pg.1152]    [Pg.1152]    [Pg.106]    [Pg.107]    [Pg.373]    [Pg.431]   
See also in sourсe #XX -- [ Pg.23 , Pg.533 ]

See also in sourсe #XX -- [ Pg.533 ]




SEARCH



Staphylococcus

© 2024 chempedia.info